SOC Telemed Return on Equity

SOC Telemed (TLMD) currently reports a ROE of -30.22%. That is below the Healthcare sector average of 13.26%. Use the charts on this page to explore SOC Telemed's ROE history and peer comparisons.

SOC Telemed's ROE of -30.22% is lower than the Healthcare sector average of 13.26%. That is roughly 327.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but SOC Telemed's current -30.22% should be judged against Healthcare norms (sector average: 13.26%) and against TLMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -30.22%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for SOC Telemed, and consider following TLMD for alerts when major investors trade the stock.

SOC Telemed is classified in the Healthcare sector. On ROE, it currently shows -30.22% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLMD with unrelated industries.